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Abstract. Bleeding during liver resection is a significant threat to the clinical outcome. Portal triad occlusion with complete 
ischemia of the liver flow of hepatoduodenal ligament is a well-documented, safe and useful way to reduce this problem. 
Although the technique is efficient in limiting blood loss, there is still controversy concerning potential disadvantages and 
subsequent reperfusion liver injury. A prospective analysis will include at least 30 patients 18-75 years old, who are 
undergoing liver resection due to metastases of the colorectal carcinoma. After signing the informed consent, the 
parameters will be analyzed in three phases, pre-, intra- and postoperatively. During surgery (indicated by a 
surgical/oncological team of doctors not related to our study) liver tissue samples will be taken of the “healthy liver” (not 
involved in the tumor process) in which after tissue homogenization, analysis of parameters will be done responsible for the 
development of liver injury. This research will not affect the clinical practice, course and outcome of the treatment in 
patients who are included. The study may be useful for future patients who will undergo liver resections. The application of 
modern research methods with scientific validity of statistical processing of data and the use of appropriate literature, 
significant data will be obtained about the character, i.e. intensity of damage of the liver tissue in patients undergoing liver 
resections. 
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The latest achievements in liver resection surgery and 
significant progress in preoperative estimation, prepara-
tion and postoperative monitoring and patient care ex-
panded the indications and range of liver resection pro-
cedures. The most important problem during hepatec-
tomy is mandatory control of bleeding from the liver 
parenchyma. Uncontrolled intra- and postoperative 
bleeding from the resected liver is still the most severe 
negative prognostic factor which is in direct correlation 
with immediate postoperative morbidity and mortality 
[1,2,3]. Besides the immediate metabolic and cardiocir-
culatory consequences of hypovolemia of different de-
gree, secondary negative effects of excessive bleeding 
during liver resection are increased need for postopera-
tive transfusion of fresh blood, i.e. blood components 
and derivatives which are proven to be linked to critical 
coagulopathies and immunity decrease and shorter post-
operative disease-free interval in liver malignancies 
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[4,5]. The intent to overcome this key problem resulted 
during the last three decades of the last century in the 
development of a range of different methods of vascular 
control, or vascular liver isolation, which depend on the 
location of the lesion in the liver. The condition of the 
liver parenchyma and the general condition of the pa-
tient may cause a complete or partial vascular isolation 
or transitory liver ischemia by occlusion of inflowing 
and/or outflowing liver blood vessels. Temporary dis-
ruption of only the inflow, or of both inflow and out-
flow of the circulation (vascular exclusion) of the part 
or the whole liver aim to quickly (but not hastily) con-
duct anatomically precise and technically correct liver 
resections in bloodless conditions. Thanks to its ad-
vantages, first of all relatively quick and easy applica-
tion and satisfactory hemostatic results, the most sig-
nificant and most often used method of vascular isola-
tion of the liver is the Pringle maneuver. The method 
was inaugurated in 1908 [6] and it includes a complete 
interruption of the inflowing liver circulation by 
clamping of portal vain and hepatic artery, i.e. of the 
whole hepatoduodenal ligament by a vascular clamp, 
setting the tourniquet or in urgent situations with fin-
gers. However, the disadvantage of all the methods of 
vascular isolation of the liver, including the Pringle ma-
neuver, is imminent ischemic and then subsequent 
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reperfusion parenchymal liver damage. Although the 
Pringle maneuver is efficient in reducing the blood loss 
from the resected liver parenchyma, critical hepatic 
ischemia that this maneuver causes represents a serious 
limiting problem that must be taken care of, particularly 
when there is a previous liver disease with significant 
vulnerability and sensitivity of the organ to hypoxia. 
Such transitory inflow occlusion causes parenchymal 
damage which is defined as ischemia-reperfusion injury 
(IRI). Etiological basis of this injury is a decrease in the 
level of intracellular ATP due to cellular anoxia which 
leads to an increase in intracellular Ca
2+
 ion concentra-
tion [7]. Namely, decreased ATP causes a decrease in 
active transport of Ca
2+
ATPase and opening of 
Ca
2+
voltage-dependent canals during depolarization of 





ATPase because of which there is an 
increase in the exit of K
+
 ions from cells and the en-
trance of Na
+
 ions in the cells. As a result, the concen-
tration of intracellular Ca2
+
 increases significantly and 
leads to the destruction of the cytoskeleton [812]. In 
order to prevent critical ischemic damage, a timely re-
oxygenation is necessary. At the same time, however, 
this reperfusion causes reperfusion injury [1316]. 
Namely, xanthine-dehydrogenase is converted into 
xanthine-oxidase and hypoxanthine, obtained from the 
degradation of adenine-nucleotides, is accumulated in 
the ischemic organ. With the beginning of the reperfu-
sion of previously ischemic organ great amounts of 
superoxides are created from previously accumulated 
hypoxanthine by xanthinoxidase action which leads to 
the damage of the cytoplasm, proteins and DNA and 
prevents the reduction of oxygen in the mitochondria 
[10]. Then, peroxidation of the cytoplasmatic membrane 
lipids takes place which is composed of two-layered 
lipids which causes its damage. Considering literature 
data which show that ischemia reperfusion injury may 
affect the course and outcome of the treatment in terms 
of intraoperative bleeding, prolonged hospitalization, 
increased morbidity and mortality, the study is directed 
at identifying the molecular mechanisms of apoptosis 
which are initiated during ischemia and reperfusion in 
liver tissue f humans.  
Ethical Standards 
During the research, standard methods of preoperative 
preparation, operative treatment and postoperative 
monitoring were used. The participants may not have 
any direct benefit from participating in the study apart 
from more systematic monitoring and recording the 
research parameters. The study may be useful to future 
patients who will undergo liver resection. Since the re-
search does not disrupt the planned liver resection pro-
tocol the participants will not be exposed to risks related 
to the research. The research does not include the use of 
untested or new medications or the testing of new surgi-
cal interventions. The mode of patient treatment in-
cluded in the research is identical to the treatment of 
other patients with the same symptoms who were not 
included in this research and completely the same as the 
treatment applied with patients operated on at the Di-
gestive Surgery Clinic of the Clinical Center Niš. The 
patients were chosen as potential participants because of 
the planned resection of the liver. The patients may 
freely accept or reject participation in the research. The 
participation decision will not influence the mode of 
operative treatment.  
We emphasize that participation is voluntary and 
that at any given moment, at any stage, the consent may 
be withdrawn by the patient. The data obtained in the 
research will be available only to the research team be-
cause they are confidential. After informing the patients 
and obtaining signed consent, every patient is given a 
code number which will be used for storing all the in-
formation related to treatment. The conclusions ob-
tained during the research will published and available 
to public. Confidential data will not be published.  
Material and Methods 
Prospective analysis will include at least 30 patients 
aged 1875 who are undergoing liver resection due to 
metastases of the colorectal carcinoma. The patients 
included in the research has resectable metastases and 
were not undergoing neoadjuvant chemotherapy. After 
signing the informed consent, the parameters will be 
analyzed in three stages, pre-, intra- and postoperatively. 
Including and excluding criteria are shown in Table 1. 
During surgery (indicated by surgical/oncological team 
Table 1 Inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
 Confirmed diagnosis of adenocarcinoma of the 
colorectum after curative surgery 
 Resectable CRC liver metastasis 
 No evidence of distant metastases 
 No prior chemotherapv for metastatic disease 
 Age > 18 years <75 
 No infections requiring systemic antibiotic treatment 
 Local recurrence of colorectal cancer 
 Patients with previous liver injury 
 Patients with prior liver surgery 
 Patients who in previous surgery underwent portal vein 
 ligation 
 HCV or HBV infection 
 liver cirrhosis 
 Patients with a history of anv arterial thrombotic event 
 within the past 6 months, including angina (stable or 
unstable), MI, or CVA 
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independent of our research) samples of liver tissue of 
healthy liver (not involved in tumor process) will be 
taken in which, after tissue homogenization, an analysis 
of parameters responsible for the development of is-
chemia reperfusion injury will be done.  
Preoperative parameters: demographic data (age and 
sex), standard preoperative investigations which examine 
liver function in all patients included in the research 
(alkaline phosphatase, AST, ALT, γGT, bilirubin, LDH, 
albumin, alpha-fetoprotein), as well as the presence of 
metabolic syndrome (glucose  6.1 mmol/L; serum 
triglycerides  1.7 mmol/L; serum HDL cholesterol 
<1.04 mmol/L; blood pressure  130/85 mm Hg). 
Intraoperative parameters: surgical approach, type 
and resection circumference, intraoperative blood loss, 
intraoperative blood compensation, liquid compensation 
and duration of surgery. During surgery, samples of liver 
tissue will be taken from the resection area. Liver tissue 
samples represent the tested groups. Three groups will be 
formed (I – control group, II – tissue samples during is-
chemia, III – samples after tissue reperfusion) further 
divided into seven subgroups based on the time the sam-
ple was taken. At zero minute, one sample is taken (con-
trol group), then after ischemia of hepatoduodenal liga-
ment (group II) samples are taken within subgroups at 5, 
10 and 15 minutes of ischemia. After ischemia, samples 
are taken (group III) within subgroups at 1, 3 and 5 
minutes (Diagram 1). All samples will be stored in spe-
cial containers and frozen at -80
o
C. The tissue sample and 
the patient are given a code number. The research will be 
conducted at the Laboratory for Functional Genomics and 
Proteomics of the Scientific-Research Center of the Fac-
ulty of Medicine, University of Niš. In order to estimate 
the biochemical parameters of programmed cell death the 
liver tissue was first cut into small pieces and then finely 
cut in ice cold water with a homogenization apparatus. 
The homogenate (10% v/v) will be centrifuged at 1500 
rpm for 10 minutes at 4
0
C. The activity of caspase -3, 
acidic DNaseand Bax protein concentration will be de-
termined in the supernatant. Caspase-3 will be deter-
mined with commercial ELISA kit (Cusabio Technology 
LLC, USA). The activity of acidic DNase (DNase-2) will 
be measured using the method of Bartholeyns et al., (1975) 
and the formed acid-soluble nucleotides were measured 
spectrophotometrically. Enzymes activity was expressed in 
international units in gram of protein (U/g protein). The 
concentration of Bax protein in liver homogenate will be 
determined with a commercial ELISA kit (Human Apop-
tosis regulator BAX ELISA Kit, cusabio Technology LLC, 
USA). The activity of the enzymes of alkaline phosphatase 
(AF), aspartate aminotransferase (AST), alanine ami-
notransferase (ALT), gamma-glutamyl transferase (GGT) 
and lactate dehydrogenase (LDH) in serum will be deter-
mined with commercial Sigma tests (St. Louis, MO, USA) 
using the spectrophotometric method at the Central La-
boratory of the Clinical Center Niš. 
Postoperative parameters: The postoperative liver 
function as well as the presence of metabolic stress will 
be monitored by analyzing patients‟ blood samples at 
the Central Laboratory of the Clinical Center Niš as part 
of control postoperative monitoring. 
The Aim of the Research  
The research deals with problems accompanying the 
occlusion of the portal triad and tissue damage at mo-
lecular level in patients who need some of the liver re-
sections in terms of ischemia during resection and later 
liver tissue reperfusion.  
  
Diagram 1 Intraoperative sampling of the liver tissue 
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End points: 
1. Determine the degree of apoptosis of the liver paren-
chyma intraoperatively during ischemia and during 
tissue reperfusion in specific time intervals (the ac-
tivity of caspase-3 and deoxyribonuclease-II will be 
determined as well as the level of Bax protein in 
liver tissue). 
2. Determine preoperatively and postoperatively the 
condition of liver parenchyma by determining the 
biochemical parameters of the liver function (the ac-
tivity of the alkaline phosphatase enzyme, AST, 
ALT, γGT,biliubin, LDH, albumin, alpha-fetopro-
tein, urea) and the parameters of metabolic syn-
drome (glucose, serum triglycerides, serum HDL 
cholesterol, blood pressure). 
3. Determine the correlation of apoptosis parameters 
with functional tests of the liver during ischemia and 
reperfusion.  
Statistical Analysis 
The estimation was done by double testing of the null 
hypothesis with independent t-test with accepted values 
of type I error α=0,05and power of the study 90%. The 
total study sample is 30 participants. Sample size was 
calculated in G power program 3.1.9.2. On the basis of 
the gathered data, a database will be created in software 
package SPSS 20.0 which will be used for further sta-
tistical analysis. Statistical analysis of data will include 
the methods of descriptive and analytical statistics. The 
results will be represented in tables and graphs. All at-
tributive characteristics of the monitoring are described 
in absolute and relative numbers. The description of 
numerical forms of monitoring we will use the measures 
of averages (median and arithmetic mean) and standard 
deviation. The choice of tests used for numeric obser-
vations depend on the nature of the distribution of the 
numeric markings of observation and group number. 
Normal distribution will be tested using Kolmogorov-
Smirnov test. The testing of the hypothesis of equality 
of mean values in cases when two groups exist will be 
done by t-test for dependent or independent samples in 
case of normal distribution and Wicoxon test for de-
pendent and Mann-Whitney test for independent sam-
ples when distribution is nor normal. If three groups 
exist, ANOVA (one-way analysis of variance) test will 
be used for normal distribution and Kruskal-Wallis test 
for other than normal distribution of data. For correla-
tion analysis, Pearson correlation coefficient will be 
used with normal distribution or Spearman coefficient 
correlation when distribution is not normal. For deter-
mining the link between the tested parameters and the 
genotypes of the tested polymorphism univariate and 
multivariate logistic regression analysis will be used. 
Statistical hypothesis will be tested on the level of sig-
nificance for risk of α=0.05. i.e. the difference between 
the samples will be considered significant at p<0.05. 
Discussion 
The liver is an organ which contains the most macro-
phages compared to other organs in the body and it has 
the ability to secrete oxygen radicals and tissue toxic 
mediators. This biological characteristic of the liver may 
lead to higher sensitivity. i.e. susceptibility to ischemic 
damage. The examination of the ischemic-reperfusion 
injury was done mostly on experimental models. In the 
last two decades of the last century the accumulated 
evidence has shown that the ischemic reperfusion injury 
of the liver is induced or potentiated by the action i.e. 
metabolism of several toxic chemical mediators such as 
reactive (free) oxygen radicals, proteases (elastase), 
inflammatory cytokines, thrombocyte-activating factor, 
vasoconstrictors endothelin and thromboxane etc., i.e. 
by pathophysiological events in which they participate 
(neutrophil infiltration and their adhesion to hepatic 
sinusoidal endothelial cells, elastase hyperproduction, 
sinusoid constriction and microcirculation damage, 
apoptosis, degradation of phospholipid cell membrane 
etc. [9,15]. On the basis of these pathophysiological 
mechanisms of ischemia reperfusion injury numerous 
strategies have been suggested for its prophylaxis and 
treatment the majority of which are based on the inhibi-
tion of negative effect mostly of oxygen radicals, in-
flammatory toxins and adhesion molecules and cascad-
ing processes in which they participate [17]. The edema 
of sinusoidal and Kupfer cells after ATP depletion dur-
ing liver ischemia, increased production of strong en-
dothelin vasoconstrictor and probably decreased NO 
production are pathophysiological mechanisms which 
contribute to the reduction of sinusoidal lumen [10]. 
Apoptosis or programmed cell death has a key role in 
many biological processes. Its determination is highly 
significant in various fields of modern medicine. In this 
case it represents the beginning of hepatocyte damage 
which leads to permanent damage. In order to determine 
the degree of programmed cell death, we can use mark-
ers such as caspase-3 – enzymes which initiate the 
apoptosis process, acidic DNase (DNase-2) which is the 
final stage of apoptosis – it disintegrates the nucleus 
material and BAX protein which points to the mito-
chondrial pathway of apoptosis activation. Since the 
effects of ischemia and reperfusion are the initiators of 
apoptosis which has several levels – we have chosen 
these parameters in order to determine the degree of 
programmed cell death. Based on the level of apoptosis 
we can conclude whether the patients should be admin-
istered apoptosis inhibitors to prevent cell death. So far, 
the researches in ischemia reperfusion injury mecha-
nism were done mostly on experimental models which 
included working on lab animals (ex hominem) or tissue 
cultural (ex situ or in vitro examinations). In addition, 
clinical and experimental investigations are ethically 
inacceptable or technically undoable in the majority of 
conditions and diseases which cause this syndrome, 
except determining some parameters from systematic or 
local circulation, in other words-it is impossible to de-
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termine them in the tissue involved with ischemia- 
reperfusion injury. Therefore, we believe that the most 
precise examination of injury mechanisms can be 
achieved by analyzing the listed parameters from liver 
tissue homogenate collected during resection interven-
tion on the liver. Standard clinical liver resection proce-
dure during which temporary ischemia and subsequent 
reperfusion are induced have enabled developing a 
unique experimental model during which samples are 
taken „in situ‟ and „in vivo‟ from “healthy liver” (not 
involved in the tumor process) in which after tissue ho-
mogenization the parameters responsible for the devel-
opment of ischemia reperfusion injury is done. 
Conclusion 
The significant progress in liver resection techniques as 
well as new treatment methods have brought about im-
provement in the quality of life and longer survival of 
patients with liver damage who need some of the resec-
tion procedures in treatment. However, contrary to these 
favoring factors, resection procedures carry the risk of 
liver tissue damage which in many cases many jeop-
ardize patient‟s life.  
Having in mind the small number of such and simi-
lar experimental studies, the application of modern re-
search methods, with scientific validity of statistical 
data analysis and the use of literature, it is expected that 
significant data about the character i.e. the intensity of 
liver tissue injury in patients during resection proce-
dures of the liver will be obtained. 
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